CapZ-α is a pivotal protein constituent of the CapZ complex, integral to the dynamic capping activity at the barbed ends of actin filaments. This capping is crucial for the stabilization and organization of actin filament assembly, which underpins a multitude of cellular processes. The actin cytoskeleton, a structure vital for maintaining cell shape, motility, and division, is regulated in part by CapZ-α. Its expression and function are essential for the proper operation of muscle contractions, cellular movements, and a host of signaling pathways. The regulation of CapZ-α expression is complex, involving numerous signaling cascades and transcriptional networks, reflecting its importance in cellular homeostasis and function. The precise control of CapZ-α levels in cells is a reflection of the tightly orchestrated interplay between various biomolecular pathways that ensure the maintenance of cellular architecture and responsiveness to internal and external cues.
Investigating the realm of chemical activators, a range of compounds have been identified that could play a role in the upregulation of CapZ-α expression. These include molecules that interact with cellular signaling pathways and epigenetic modifiers. For instance, compounds like retinoic acid could increase the transcription of CapZ-α by binding to nuclear receptors that interact directly with DNA to upregulate gene expression. Histone deacetylase inhibitors such as Trichostatin A and Sodium Butyrate are known to induce a more open chromatin structure, thereby enhancing the transcriptional activity of genes, including that of CapZ-α. Forskolin, by raising intracellular cAMP levels, could activate protein kinase A and downstream elements that stimulate the transcription of a range of genes. Similarly, modulators of the Wnt signaling pathway, such as Lithium Chloride, might indirectly upregulate CapZ-α expression through alterations in cellular signal transduction mechanisms. All these compounds, among others, are considered to be of interest for their ability to influence the expression of CapZ-α, shining a light on the complex regulatory networks that dictate the protein's levels within cells. It's important to note that while these compounds have been shown to influence gene expression broadly, their specific effects on CapZ-α would necessitate detailed and focused biological studies.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid might upregulate CapZ-α expression through activation of retinoic acid receptors, which are known to promote transcription of specific genes. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methylation, 5-Azacytidine could lead to the demethylation of the CapZ-α gene promoter and subsequent increase in its transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could elevate CapZ-α levels by preventing deacetylation of histones, thus loosening chromatin structure around the gene and promoting gene expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin may stimulate CapZ-α expression by elevating cyclic AMP, which activates protein kinase A, leading to the activation of transcription factors that target the CapZ-α gene. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone may induce CapZ-α expression through interaction with glucocorticoid response elements in the gene's promoter region, leading to increased gene transcription. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride could increase gene transcription of CapZ-α by inhibiting GSK-3β, thus activating the Wnt signaling pathway and potentially leading to the upregulation of CapZ-α. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate might stimulate CapZ-α expression by inhibiting histone deacetylases, thereby increasing histone acetylation and enhancing gene transcription. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol can increase levels of cAMP, potentially leading to the activation of a cAMP-dependent signaling cascade that may upregulate the expression of CapZ-α. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 might promote CapZ-α expression by inhibiting MEK, which is part of the ERK/MAPK pathway; this inhibition could lead to the derepression of transcription factors that stimulate CapZ-α gene transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could indirectly stimulate CapZ-α synthesis by inhibiting the mTOR pathway, which might lead to compensatory mechanisms that upregulate certain genes, including CapZ-α. | ||||||